Friday March 26th 2021
Look for vaccination dosage
Biontech tests on younger children
The effectiveness of vaccines in children has not yet been researched. After an initial test run on teenagers, Biontech and Pfizer are testing the safety and tolerability of their vaccine on significantly younger people. The competition was faster there, however.
After the competitors Moderna and Astrazeneca, the Mainz company Biontech and its US partner Pfizer have also started testing their corona vaccine on younger children. “Together with our partner Biontech, we administered a dose to the first healthy children in a global ongoing phase 1/2/3 study,” Biontech announced to ntv. Pfizer is testing three different dosages in the younger children. The company expects around 4,500 children to take part in the study.
The clinical tests are intended to examine the safety, tolerability and effectiveness of the vaccine in children between six months and eleven years of age, it said. “We are proud to conduct this much-needed study for children and families eagerly awaiting a potential vaccination option,” said Pfizer. Hopefully the vaccine can also be used in this age group from the beginning of next year.
The company had previously already started testing its corona vaccine based on mRNA technology in children between the ages of twelve and 15. The US company Moderna and the British-Swedish pharmaceutical company Astrazeneca had already started testing their corona vaccines on younger children before Biontech / Pfizer. The US manufacturer Johnson & Johnson plans to follow suit soon.
As a rule, children are spared severe Covid-19 diseases, but there are also isolated cases of serious diseases and even deaths. In addition, a corona infection can trigger the dangerous inflammatory syndrome MIS-C in children. That being said, infected children can pass on the novel coronavirus. In many countries, children must also be vaccinated in order to achieve herd immunity.